Recherche avancée
Affichage des résultats 421 à 440 sur 6914 au total
-
A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers.
Benjamin Ribba, Emmanuel Watkin, Michel Tod, Pascal Girard, Emmanuel Grenier, Benoît You, Enrico Giraudo, Gilles Freyer
-
Links between cyclosporin exposure in tissues and graft-versus-host disease in pediatric bone marrow transplantation: analysis by a PBPK model
C. Gerard, Nathalie Bleyzac, Pascal Girard, G. Freyer, Y. Bertrand, M. Tod
-
Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4
Marion Bouillon-Pichault, Vincent Jullien, Caroline Bazzoli, Gérard Pons, Michel Tod
-
Model-based design of rituximab dosing optimization in follicular non-hodgkin lymphoma
David Ternant, Guillaume Cartron, E. Henin, Michel Tod, Pascal Girard, Gilles Paintaud
-
A Pharmacokinetic-Pharmacodynamic Model for Predicting the Impact of CYP2C9 and VKORC1 Polymorphisms on Fluindione and Acenocoumarol During Induction Therapy
Dr Verstuyft, Xavier Delavenne, Alexandra Rousseau, Annie Robert, Michel Tod, Bertrand Diquet, Martine Lebot, Patrice Jaillon, Laurent Becquemont
-
A pharmacodynamic model of ganciclovir antiviral effect and toxicity for lymphoblastoid cells suggests a new dosing regimen to treat cytomegalovirus infection
A. Janoly-Dumenil, I. Rouvet, Nathalie Bleyzac, F. Morfin, Mt. Zabot, M. Tod
-
Prédiction quantitative des interactions médicamenteuses impliquant les cytochromes 3A4 et 2D6 : approche in vivo
Sylvain Goutelle, M. Tod
-
A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy.
Benjamin Ribba, Gentian Kaloshi, Mathieu Peyre, Damien Ricard, Vincent Calvez, Michel Tod, Branka Cajavec-Bernard, Ahmed Idbaih, Dimitri Psimaras, Linda Dainese, Johan Pallud, Stéphanie Cartalat-Carel, Jean-Yves Delattre, Jérôme Honnorat, Emmanuel Grenier, François Ducray
-
Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.
Tristan Ferry, Agathe Sénéchal, Marie-Claude Gagnieu, André Boibieux, Frédéric Laurent, Thomas Perpoint, Michel Tod, Christian Chidiac
-
Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure
Anne-Charlotte Castellan, M. Tod, François Gueyffier, M. Audars, F. Cambriels, Berouz Kassai, Patrice Nony
-
In Vivo Quantitative Prediction of the Effect of Gene Polymorphisms and Drug Interactions on Drug Exposure for CYP2C19 Substrates
Sylvain Goutelle, Laurent Bourguignon, Nathalie Bleyzac, J. Berry, F. Clavel-Grabit, M. Tod
-
Impact of Genetic Polymorphism on Drug-Drug Interactions Mediated by Cytochromes: A General Approach
M. Tod, C. Nkoud-Mongo, François Gueyffier
-
Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice.
Floriane Lignet, Sébastien Benzekry, Shelby Wilson, Frédérique Billy, Olivier Saut, Michel Tod, Benoit You, A. Adda Berkane, S. Kassour, M. X. Wei, Emmanuel Grenier, Benjamin Ribba
-
How to solve the problem of spontaneous bacterial clearance when testing new antibiotic treatment: results on experimental pneumonia due to a derepressed cephalosporinase-producing Enterobacter cloacae
Anne Jacolot, Claire Judel, Kamel Louchahi, Michel Tod, Sandrine Marchand, Olivier Petitjean, Olivier Mimoz
-
Antimicrobial-Related Severe Adverse Events during Treatment of Bone and Joint Infection Due to Methicillin-Susceptible Staphylococcus aureus
Florent Valour, Judith Karsenty, Anissa Bouaziz, Florence Ader, Michel Tod, Sebastien Lustig, Frédéric Larent, René Ecochard, Christian Chidiac, Tristan Ferry
-
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial
Olivier Lortholary, Caroline Roussillon, Céline Boucherie, Christophe Padoin, Marie-Laure Chaix, Guillaume Breton, Agathe Rami, Nicolas Veziris, Olivier Patey, Eric Caumes, Thierry May, Jean-Michel Molina, Jérôme Robert, Michel Tod, Catherine Fagard, Geneviève Chêne
-
Identification of Most Aggressive Carcinoma Among Patients Diagnosed With Prostate Cancer Using Mathematical Modeling of Prostate-Specific Antigen Increases
Charry F. De, O. Colomban, Benoit You, A. Ruffion, P. Paparel, M. Wilbaux, M. Tod, G. Freyer, P. Perrin
-
Identification des lacunes de connaissances des étudiants en filière officine débutant le stage de 5e année : propositions pour modifier le contenu de l’enseignement
B. Charpiat, S. Derfoufi, M. Larger, A. Janoly-Dumenil, C. Mouchoux, Benoit Allenet, M. Tod, J. Grassin, R. Boulieu, O. Catala, P. Bedouch, Joëlle Goudable, C. Vinciguerra
-
Identification des lacunes de connaissances des étudiants en filière officine débutant le stage de 5e année
B. Charpiat, S. Derfoufi, M. Larger, A. Janoly-Dumenil, C. Mouchoux, B. Allenet, M. Tod, J. Grassin, R. Boulieu, O. Catala, P. Bedouch, Joëlle Goudable, C. Vinciguerra
-
Conduite à tenir en cas d’association d’un alpha-bloquant et d’un inhibiteur puissant du cytochrome 3A4
N. Bensalah, S. Garcia, F.X. Rose, P. Bedouch, O. Conort, M. Juste, R. Roubille, Benoit Allenet, M. Tod, B. Charpiat